Patent · US Expired

Monoclonal anti-ganglioside antibody and its preparation

US5730981A · kind A · utility

2Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 1994
Grant dateMar 24, 1998
Priority date
Expiry dateOct 20, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to monoclonal antibodies of high avidity, which react specifically with the gangliosides GD3 and GQ1b, and to their use for detecting melanomas and other tumors or tissues expressing GD3 and GQ1b.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.